San Francisco, CA, USA
50+ people
Private
Founded 2015
$98M Series B announced in 2021
Biotechnology
Drug Discovery
Artificial Intelligence
About
Verge uses artificial intelligence and human data to develop better drugs faster. Verge has an end-to-end technology-driven drug discovery and development platform, featuring one of the field’s largest and most comprehensive proprietary patient genomics datasets from human tissue. Verge uses machine learning to mine this data and develops these insights into new drugs using it’s human-centric biology and chemistry platforms.
Funding history
- Series B$98M2021-12-16
